In contrast to the increase of IL-10 levels in plasma, Mo from HUS patients exhibited a lower capacity to produce this anti-inflammatory cytokine in vitro, both under basal conditions and after stimulation with LPS, compared with the control group. This evidence concerns the gene IL10 and hemolytic-uremic syndrome.